resident Donald Trump wants to remake the Food and Drug Administration. And he happens to have a “fantastic person” in mind to do it, he said Tuesday — someone who will turn the agency into an industry-friendly shop that cranks out new cures on the double.

But does anyone really want a deregulated FDA? STAT canvassed biopharma insiders, physicians, Wall Street analysts, and FDA veterans. Their verdict: Trump’s plan sounds like a solution in search of a problem.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Reply to Dr. Sumant Baukhandi Cancel reply

Please enter your name.
Please enter a comment.

  • If Trump can bring sweeping changes in the structure of FDA and a FDA Moderation Act to make medicines available to patients at affordable price, it will be welcome with open arms. Deregulation cannot happen – however, moderation can. Medicines require regulation but with well defined stages of regulation. Drug Development studies should be done with cell lines and not on human beings. Our science has advanced so much that new technologies can be introduced for drug development – cutting development cost and time. FDA should have experts from industry coopted for special task force teams for the Moderation Act.

  • très bonne chose pour les patients en train de mourir sans aucun espoir, pour ces gens là, un jour compte, une heure même un e minute
    Pour des fonctionnaires de la FDA, ils ont tout leur temps, pourquoi prendrait-il me plus petit risque
    Trump a de la compassion, formidable président

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.